Figure Legends
Figure 1. Comparison of intra-procedural ACT kinetics among oral
anticoagulants. A. Baseline ACT before first UFH shot. B. Time to reach
optimal ACT >300 sec. ACT, activated clotting time; UFH,
unfractionated heparin. A, apixaban; D, dabigatran; E, edoxaban; R,
rivaroxaban; W, warfarin.
Figure 2. Comparison of SCE incidence among oral
anticoagulants. SCE, silent cerebral event. A, apixaban; D, dabigatran;
E, edoxaban; R, rivaroxaban; W, warfarin.